Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

7.86USD
15 Jun 2018
Change (% chg)

-- (--)
Prev Close
$7.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,441
52-wk High
$15.75
52-wk Low
$5.48

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 1 5.00 5.00 5.00 --
Year Ending Apr-18 1 8.60 8.60 8.60 --
Year Ending Apr-19 1 14.40 14.40 14.40 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 1 -0.26 -0.26 -0.26 --
Year Ending Apr-18 1 -1.73 -1.73 -1.73 --
Year Ending Apr-19 1 -1.59 -1.59 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.97 34.18
P/E High - Last 5 Yrs. -- 41.94 47.65
P/E Low - Last 5 Yrs. -- 23.88 25.16
Beta -- 0.79 0.78
Price to Sales (TTM) 23.13 3.65 8.57
Price to Book (MRQ) 2.97 3.81 4.35
Price to Tangible Book (MRQ) 2.97 4.72 6.03
Price to Cash Flow (TTM) -- 20.36 22.78
% Owned Institutions 67.00 1.27 2.40

Dividends

  Company industry sector
Dividend Yield -- 1.81 1.67
Dividend Yield - 5 Year Avg -- 1.50 1.42
Dividend 5 Year Growth Rate -- -9.55 -6.56
Payout Ratio(TTM) -- 41.65 39.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 839.92 4.00 5.00
Sales (TTM) vs TTM 1 Yr. Ago 1,263.57 10.42 12.50
Sales - 5 Yr. Growth Rate -- 7.18 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago 51.40 44.95 40.63
EPS (TTM) vs TTM 1 Yr. Ago 80.06 -- --
EPS - 5 Yr. Growth Rate -- 6.44 8.03
Capital Spending - 5 Yr. Growth Rate -- 6.79 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.59 2.56
Current Ratio (MRQ) 2.73 3.68 3.64
LT Debt to Equity (MRQ) 0.41 10.51 12.92
Total Debt to Equity (MRQ) 1.19 14.61 17.37
Interest Coverage (TTM) -30.32 40.42 35.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.30 54.96
Gross Margin - 5 Yr. Avg. -- 52.75 52.86
EBITD Margin (TTM) -563.85 -- --
EBITD - 5 Yr. Avg -- 18.47 15.70
Operating Margin (TTM) -567.67 14.39 -0.76
Operating Margin - 5 Yr. Avg. -- 14.19 10.94
Pre-Tax Margin (TTM) -527.54 14.67 1.32
Pre-Tax Margin - 5 Yr. Avg. -- 14.42 11.12
Net Profit Margin (TTM) -527.54 11.27 -1.97
Net Profit Margin - 5 Yr. Avg. -- 10.75 7.48
Effective Tax Rate (TTM) -- 21.65 29.90
Effective Tax Rate - 5 Yr. Avg. -- 23.66 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 847,259,560 736,829,609
Net Income/Employee (TTM) -- 98,722,633 85,814,668
Receivable Turnover (TTM) 0.89 5.94 6.06
Inventory Turnover (TTM) -- 2.57 3.65
Asset Turnover (TTM) 0.07 0.90 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -36.96 10.86 10.37
Return on Assets - 5 Yr. Avg. -- 11.66 11.09
Return on Investment (TTM) -49.99 13.65 13.17
Return on Investment - 5 Yr. Avg. -- 15.12 14.39
Return on Equity (TTM) -61.02 15.43 15.15
Return on Equity - 5 Yr. Avg. -- 16.33 15.73
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.00%
# of Holders: 32
Total Shares Held: 7,233,408
3 Mo. Net Change: 12,339
# New Positions: 4
# Closed Positions: 5
# Increased Positions: 10
# Reduced Positions: 12
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.